Given the volume of compounded GLP1 products being marketed directly to consumers and associated safety concerns, it makes sense that FDA is unlikely to deprioritize the issue
Your appetite dropped
Administration and Safety TB-500 Administration: Commonly given via subcutaneous injection Typically used in 46 week cycles Initial phase: 23 injections per week Maintenance phase: Reduced frequency as directed by a healthcare provider BPC-157 Administration: Can be taken via subcutaneous injection, localized injection, or oral capsule (for gut health) Dosage varies depending on injury type and severity Can be used for short-term injury recovery or longer cycles for chronic conditions Safety Note: Both TB-500 and BPC-157 should be used under medical supervision
[PMID: 2590167] PubMed record related to this compound for laboratory literature review
Some providers offer discounted rates for patients committing to longer treatment packages
Effect of Acute Exercise Mode on Serum Brain-Derived Neurotrophic Factor (BDNF) and Task Switching Performance Metabolism: Volume 64, Issue 1, January 2015, Pages 24-34 Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism Defining Clinical Leptin Resistance Challenges and Opportunities 1996 Feb 1;334(5):292-5